# Dose-Dependent Dual Effects of Gradient Ionizing Radiation on Neurocognition

**Authors:** Xiaokun Jian, Beier Jiang, Sixu Li, Tianjiao Min, Yingwei Xu, Ruoshui Xu, Lina Liu, Ying He

PMC · DOI: 10.3390/ijms27041842 · 2026-02-14

## TL;DR

This paper reviews how different radiation doses affect brain function, showing harmful effects at high doses and potential benefits at low doses.

## Contribution

The paper introduces a new framework explaining radiation's dual effects on the brain and challenges the traditional linear no-threshold model.

## Key findings

- High-dose radiation causes cognitive decline through DNA damage and inflammation.
- Low-dose radiation can activate protective pathways and promote neural plasticity.
- A shift from the LNT model to a dynamic homeostasis model is needed for understanding radiation effects.

## Abstract

Ionizing radiation (IR) exerts complex, dose-dependent biphasic effects on the central nervous system (CNS). This review systematically elucidates the mechanisms underlying the impact of high- and low-dose radiation on neurocognitive function. High-dose radiation (HDR) triggers severe DNA damage, oxidative stress, and neuroinflammatory cascades, leading to neuronal dysfunction, suppression of neurogenesis, and failure of neural circuit reorganization, ultimately resulting in persistent cognitive decline. In contrast, low-dose radiation (LDR) exhibits a unique dual nature: within certain thresholds, it can activate endogenous protective pathways—including DNA repair and antioxidant defenses—thereby promoting neural plasticity and network homeostasis and demonstrating adaptive responses and neuroprotective potential. The research paradigm is shifting from the traditional linear no-threshold (LNT) model towards a dynamic homeostasis model. Future research should prioritize the development of neuroprotective strategies during radiotherapy for high-dose exposure, optimize irradiation modalities, and develop novel radioprotective agents to improve patient outcomes. For LDR, it is crucial to delineate its biological effects and explore its potential for intervening in neurodegenerative diseases. This review aims to provide an integrated theoretical framework for understanding the dose-dependent biphasic regulation of radiation on neurocognition and to outline future directions for developing related protective and therapeutic strategies.

## Full-text entities

- **Genes:** Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Trem2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 83433] {aka TREM-2, Trem2a, Trem2b, Trem2c}, Syp (synaptophysin) [NCBI Gene 20977] {aka A230093K24Rik, Syn, p38}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Prdx6-ps2 (peroxiredoxin 6 pseudogene 2) [NCBI Gene 384001] {aka Aop2-rs2, GPx*, Prdx6-rs2}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, CA3 (carbonic anhydrase 3) [NCBI Gene 761] {aka CAIII, Car3}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Syn1 (synapsin I) [NCBI Gene 20964] {aka Syn-1, Syn1-S}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 12772] {aka Cc-ckr-2, Ccr2a, Ccr2b, Ckr2, Ckr2a, Ckr2b}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 19225] {aka COX2, Cox-2, PES-2, PGHS-2, PHS II, PHS-2}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Rad51 (RAD51 recombinase) [NCBI Gene 19361] {aka Rad51a, Reca}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Rara (retinoic acid receptor, alpha) [NCBI Gene 19401] {aka Nr1b1, RAR, RARalpha1}, Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Nqo1 (NAD(P)H dehydrogenase, quinone 1) [NCBI Gene 18104] {aka Dia4, Dtd, Nmo-1, Nmo1, Nmor1, Ox-1}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, C3 (complement component 3) [NCBI Gene 12266] {aka ASP, HSE-MSF, Plp}, Atm (ataxia telangiectasia mutated) [NCBI Gene 11920] {aka C030026E19Rik}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}, Sod1 (superoxide dismutase 1, soluble) [NCBI Gene 20655] {aka B430204E11Rik, Cu/Zn-SOD, CuZnSOD, Ipo-1, Ipo1, SODC}, Icam1 (intercellular adhesion molecule 1) [NCBI Gene 15894] {aka CD54, Icam-1, Ly-47, MALA-2}, CA1 (carbonic anhydrase 1) [NCBI Gene 759] {aka CA-I, CAB, Car1, HEL-S-11}, Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Sod2 (superoxide dismutase 2, mitochondrial) [NCBI Gene 20656] {aka MnSOD, Sod-2}, Cldn5 (claudin 5) [NCBI Gene 12741] {aka MBEC1, Tmvcf}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 13385] {aka Dlgh4, PSD-95, PSD95, SAP90, SAP90A}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 17709], Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Grin1 (glutamate receptor, ionotropic, NMDA1 (zeta 1)) [NCBI Gene 14810] {aka GluN1, GluRdelta1, GluRzeta1, M100174, NMD-R1, NMDAR1}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], Dlg1 (discs large MAGUK scaffold protein 1) [NCBI Gene 13383] {aka B130052P05Rik, Dlgh1, E-dlg/SAP97, SAP-97, SAP97, mKIAA4187}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}
- **Diseases:** astrocytosis (MESH:D005911), carcinogenic (MESH:D011230), death (MESH:D003643), demyelination (MESH:D003711), neurological damage (MESH:D020196), brain injury (MESH:D001930), brain damage (MESH:D001925), neurocognitive disorders (MESH:D019965), skull-base tumors (MESH:D019292), ALL (MESH:D054198), neurovascular injury (MESH:D013901), cytotoxic (MESH:D064420), vascular injury (MESH:D057772), cerebrovascular diseases (MESH:D002561), intellectual delay (MESH:D001037), acute radiation syndrome (MESH:D054508), neuronal damage (MESH:D009410), EAE (MESH:D004681), breast cancer (MESH:D001943), depression (MESH:D003866), executive dysfunction (MESH:D006331), dementia (MESH:D003704), amyloid-related deficits (MESH:C000718787), multiple sclerosis (MESH:D009103), deterioration of (MESH:D000075902), synaptic dysfunction (MESH:C536122), impaired myelination (MESH:D020279), disability (MESH:D009069), tissue injury (MESH:D017695), Cognitive Impairment (MESH:D003072), deficits in associative memory formation (MESH:D008569), brain tumors (MESH:D001932), HDR (MESH:D011832), Inflammatory (MESH:D007249), glial dysfunction (MESH:D004194), Neurodegenerative Diseases (MESH:D019636), injury (MESH:D014947), malignant glioma (MESH:D005910), and prefrontal dysfunction (MESH:C536329), mitochondrial dysfunction (MESH:D028361), PD (MESH:D010300), neurotoxic (MESH:D020258), neural damage (MESH:D015441), behavioral abnormalities (MESH:D001523), neurocognitive failure (MESH:D051437), AD (MESH:D000544), neurogenesis (MESH:D001750), cancer (MESH:D009369), behavioral deficits (MESH:D019958), impairment of BBB (MESH:C536830), traumatic brain injury (MESH:D000070642), neuroinflammation (MESH:D000090862), CNS damage (MESH:D002493), intelligence (MESH:C538142), white matter injury (MESH:D056784), autoimmune disease (MESH:D001327), DNA Damage (MESH:D004266), deficits in memory, learning, and executive function (MESH:D007859), HSP (MESH:D010411), neurobehavioral abnormalities (MESH:D019954)
- **Chemicals:** BioRender (-), ATP (MESH:D000255), GSH (MESH:D005978), lipid (MESH:D008055), hydrogen (MESH:D006859), ROS (MESH:D017382), cGMP (MESH:D006152), memantine (MESH:D008559), carbon (MESH:D002244), water (MESH:D014867), glutamate (MESH:D018698)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** P301S

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940269/full.md

---
Source: https://tomesphere.com/paper/PMC12940269